Prognostic value of PD-L1 combined positive score in colorectal adenocarcinoma
Journal of Pathology and Translational Medicine · 15.11.2026 · 60 (6) · 611-624
DOI: 10.4132/jptm.2026.08.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pathology and Translational Medicine, erschienen am 15.11.2026. Verfasst von Thi Thanh Xuan Le und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hanoi Medical University, Hanoi, Vietnam. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The prognostic significance of programmed cell death ligand 1 (PD-L1) in colorectal adenocarcinoma remains unclear. We evaluated the clinicopathological and prognostic relevance of the PD-L1 combined positive score (CPS).
Methods
This single-center retrospective cohort included 124 patients with histopathologically confirmed colorectal adenocarcinoma; PD-L1 was assessed by CPS. Disease-free survival (DFS) and overall survival (OS) were evaluated using Kaplan-Meier methods and parsimonious Cox regression, and early recurrence within 12 months of curative-intent treatment with a truncated Cox model.
Results
Higher CPS was significantly associated with nodal stage (p = .012), lymphovascular invasion (p = .006), and tumor necrosis (p = .047). CPS correlated very strongly with immune-cell PD-L1 (rho = 0.945, p < .001) and strongly with tumor-cell PD-L1 (rho = 0.853, p < .001). CPS >5 remained associated with favorable DFS in a prespecified parsimonious multivariable model (adjusted hazard ratio [HR], 0.17; 95% confidence interval [CI], 0.04 to 0.75; p = .019). No PD-L1 metric was significantly associated with OS; however, CPS showed a numerically favorable but non-significant trend (adjusted HR, 0.17; 95% CI, 0.02 to 1.30; p = .088). In the exploratory early recurrence analysis, CPS >5 was associated with a lower risk of early recurrence in a model adjusted only for nodal stage (adjusted HR, 0.21; 95% CI, 0.05 to 0.94; p = .042).
Conclusions
PD-L1 CPS may serve as a complementary, hypothesis-generating prognostic marker in colorectal adenocarcinoma, particularly for disease-free survival. However, the lack of mismatch repair (MMR)/microsatellite instability (MSI) data prevents definitive conclusions regarding an MMR/MSI-independent prognostic effect. Further validation in larger, prospectively collected, multicenter cohorts with comprehensive molecular annotation is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hanoi Medical University, Hanoi, Vietnam.
- Department of Pathology, 108 Military Central Hospital, Hanoi, Vietnam.
- K Hospital (Quan Su Campus), Hanoi, Vietnam.
- Vietnamese-German Center for Medical Research, 108 Military Central Hospital, Hanoi, Vietnam.
- Vietnamese-German Center for Medical Research, 108 Military Central Hospital, Hanoi, Vietnam. nghiemxuanhoan@108-icid.com.
- Department of Military Science, 108 Military Central Hospital, Hanoi, Vietnam. nghiemxuanhoan@108-icid.com.
Zitieren
APA
Le, T. T. X., Nguyen, V. C., Ngo, T. M. H., Le, T. H., Le, M. S., Le, H. S., & Nghiem, X. H. (2026). Prognostic value of PD-L1 combined positive score in colorectal adenocarcinoma. Journal of Pathology and Translational Medicine, 60(6), 611-624. https://doi.org/10.4132/jptm.2026.08.24
Vancouver
Le TTX, Nguyen VC, Ngo TMH, Le TH, Le MS, Le HS, et al. Prognostic value of PD-L1 combined positive score in colorectal adenocarcinoma. Journal of Pathology and Translational Medicine. 2026;60(6):611-624. doi:10.4132/jptm.2026.08.24
BibTeX
@article{Le2026,
author = {Le, Thi Thanh Xuan and Nguyen, Van Chu and Ngo, Thi Minh Hanh and Le, Thi Hue and Le, Minh Son and Le, Huu Song and Nghiem, Xuan Hoan},
title = {Prognostic value of PD-L1 combined positive score in colorectal adenocarcinoma},
journal = {Journal of Pathology and Translational Medicine},
year = {2026},
volume = {60},
number = {6},
pages = {611--624},
doi = {10.4132/jptm.2026.08.24}
}
EUVIMED